{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:58:45Z","timestamp":1794959925035,"version":"4.9.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118097","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T01:56:55Z","timestamp":1594778215000},"page":"118097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics"],"prefix":"10.1016","volume":"257","author":[{"given":"Mitra","family":"Abbasifard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118097_bb0005","series-title":"Coronavirus Disease 2019 (COVID-19): Situation Report","first-page":"67","author":"Organization, W.H","year":"2020"},{"key":"10.1016\/j.lfs.2020.118097_bb0010","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2020.3072","article-title":"COVID-19\u2014new insights on a rapidly changing epidemic","volume":"323.14","author":"del Rio","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2020.118097_bb0015","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1016\/S2214-109X(20)30068-1","article-title":"Potential association between COVID-19 mortality and health-care resource availability","volume":"8.4","author":"Ji","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0020","first-page":"1","article-title":"2019 novel coronavirus (COVID-19) outbreak: a review of the current literature","volume":"4","author":"Sahin","year":"2020","journal-title":"EJMO"},{"key":"10.1016\/j.lfs.2020.118097_bb0025","first-page":"E014","article-title":"Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia","volume":"43","author":"Sun","year":"2020","journal-title":"Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases"},{"key":"10.1016\/j.lfs.2020.118097_bb0030","article-title":"SARS-CoV-2 invades host cells via a novel route: CD147-spike protein","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"issue":"21","key":"10.1016\/j.lfs.2020.118097_bb0035","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","article-title":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus","volume":"78","author":"Marzi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.118097_bb0040","series-title":"A Hint on the COVID-19 Risk: Population Disparities in Gene Expression of Three Receptors of SARS-CoV","author":"Cai","year":"2020"},{"issue":"2","key":"10.1016\/j.lfs.2020.118097_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"1312","key":"10.1016\/j.lfs.2020.118097_bb0050","article-title":"The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?","volume":"11","author":"Abassi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.118097_bb0055","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323.14","author":"Bai","year":"2020","journal-title":"Jama"},{"issue":"10223","key":"10.1016\/j.lfs.2020.118097_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118097_bb0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323.11","author":"Wang","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2020.118097_bb0070","first-page":"1","article-title":"Are Iranian sulfur mustard-exposed survivors more vulnerable to SARS-CoV-2: some similarity in their pathogenesis","author":"Farnoosh","year":"2020","journal-title":"Disaster medicine and public health preparedness"},{"key":"10.1016\/j.lfs.2020.118097_bb0075","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.lfs.2020.118097_bb0080","article-title":"Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia","author":"Gong","year":"2020","journal-title":"medRxiv"},{"issue":"10229","key":"10.1016\/j.lfs.2020.118097_bb0085","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lfs.2020.118097_bb0090","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.lfs.2020.118097_bb0095","first-page":"1102","article-title":"Is IL-6 increased in type 2 diabetes mellitus patients independent of nephropathic complication","volume":"5","author":"Nazari","year":"2017","journal-title":"J Endocrinol Diabetes Obes"},{"issue":"4","key":"10.1016\/j.lfs.2020.118097_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1309\/LMY9ILPGSETU2CO0","article-title":"Cytokines in preterm delivery","volume":"43","author":"Arababadi","year":"2012","journal-title":"Lab. Med."},{"issue":"3","key":"10.1016\/j.lfs.2020.118097_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.6026\/97320630016219","article-title":"CoViD-19 immunopathology & immunotherapy","volume":"16","author":"Chiappelli","year":"2020","journal-title":"Bioinformation"},{"key":"10.1016\/j.lfs.2020.118097_bb0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"Su","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118097_bb0115","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/07357909309046948","article-title":"Interleukin-6","volume":"11","author":"Lotz","year":"1993","journal-title":"Cancer Investig."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115327","article-title":"A panoramic review of IL-6: structure, pathophysiological roles and inhibitors","volume":"28","author":"Kaur","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"6\u20137","key":"10.1016\/j.lfs.2020.118097_bb0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejcb.2010.10.007","article-title":"The soluble interleukin 6 receptor: generation and role in inflammation and cancer","volume":"90","author":"Chalaris","year":"2011","journal-title":"Eur. J. Cell Biol."},{"issue":"25","key":"10.1016\/j.lfs.2020.118097_bb0130","doi-asserted-by":"crossref","first-page":"15959","DOI":"10.1073\/pnas.232432399","article-title":"Structure of the extracellular domains of the human interleukin-6 receptor \u03b1-chain","volume":"99","author":"Varghese","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2020.118097_bb0135","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.biopha.2018.09.177","article-title":"The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer","volume":"108","author":"Masjedi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.lfs.2020.118097_bb0140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cellsig.2016.04.004","article-title":"Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner","volume":"28","author":"Pinno","year":"2016","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-019-2336-6","article-title":"Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"23","author":"Wang","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.lfs.2020.118097_bb0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fonc.2018.00287","article-title":"\u201cDo we know jack\u201d about JAK? A closer look at JAK\/STAT signaling pathway","volume":"8","author":"Bousoik","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2020.118097_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118097_bb0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","article-title":"Versatile functions for IL-6 in metabolism and cancer","volume":"36","author":"Mauer","year":"2015","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0165","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00000658-200201000-00015","article-title":"Interleukin-1\u03b1 and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts","volume":"235","author":"Erdag","year":"2002","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0175","first-page":"1","article-title":"ROR\u03b1 suppresses interleukin-6-mediated hepatic acute phase response","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.lfs.2020.118097_bb0180","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1074\/jbc.271.16.9503","article-title":"STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2020.118097_bb0185","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","article-title":"IL-6 switches the differentiation of monocytes from dendritic cells to macrophages","volume":"1","author":"Chomarat","year":"2000","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118097_bb0190","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","article-title":"IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation","volume":"173","author":"Park","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.lfs.2020.118097_bb0200","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000494034","article-title":"Extracellular RNA sensing by pattern recognition receptors","volume":"10","author":"Tatematsu","year":"2018","journal-title":"Journal of innate immunity"},{"key":"10.1016\/j.lfs.2020.118097_bb0205","series-title":"Regulation of Cytokine Gene Expression in Immunity and Diseases","first-page":"79","article-title":"Regulation of IL-6 in immunity and diseases","author":"Tanaka","year":"2016"},{"issue":"11","key":"10.1016\/j.lfs.2020.118097_bb0210","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20160417","article-title":"IL-6 promotes the differentiation of a subset of naive CD8+ T cells into IL-21\u2013producing B helper CD8+ T cells","volume":"213","author":"Yang","year":"2016","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-\u03b3 from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection","volume":"190","author":"Green","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2009.05.140","article-title":"TGF-\u03b2 is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23","volume":"386","author":"Morishima","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virol.2012.09.012","article-title":"Anti-viral CD8 T cells and the cytokines that they love","volume":"435","author":"Cox","year":"2013","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.lfs.2020.118097_bb0235","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3","volume":"181","author":"Fielding","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118097_bb0240","series-title":"Cytokine Storm Syndrome","first-page":"561","article-title":"IL-6 blockade in cytokine storm syndromes","author":"Barrett","year":"2019"},{"key":"10.1016\/j.lfs.2020.118097_bb0245","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1: PD-L1\/2 pathway from discovery to clinical implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125698","article-title":"Persistent foot-and-mouth disease virus infection in the nasopharynx of cattle; tissue-specific distribution and local cytokine expression","volume":"10","author":"Pacheco","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2020.118097_bb0255","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2217\/fvl.12.44","article-title":"Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis","volume":"7","author":"Martinez","year":"2012","journal-title":"Futur. Virol."},{"key":"10.1016\/j.lfs.2020.118097_bb0260","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1038\/srep10501","article-title":"TLR ligand induced IL-6 counter-regulates the anti-viral CD8+ T cell response during an acute retrovirus infection","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118097_bb0265","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2020.118097_bb0270","series-title":"The Potential Role of IL-6 in Monitoring Coronavirus Disease 2019","author":"Liu","year":"2020"},{"issue":"10","key":"10.1016\/j.lfs.2020.118097_bb0275","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/eji.201243018","article-title":"Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology","volume":"43","author":"Lauder","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"6469","key":"10.1016\/j.lfs.2020.118097_bb0280","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0285","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0290","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/jir.2019.0085","article-title":"Constitutive inflammatory cytokine storm: a major threat to human health","volume":"40","author":"Gupta","year":"2020","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.lfs.2020.118097_bb0295","series-title":"Seminars in Immunopathology","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","author":"Channappanavar","year":"2017"},{"issue":"10","key":"10.1016\/j.lfs.2020.118097_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045027","article-title":"Dynamics of a cytokine storm","volume":"7","author":"Yiu","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2020.118097_bb0305","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.5001\/omj.2020.21","article-title":"Effective treatments for bladder cancer affecting CXCL9\/CXCL10\/CXCL11\/CXCR3 axis: a review","volume":"35","author":"Nazari","year":"2020","journal-title":"Oman Medical Journal"},{"key":"10.1016\/j.lfs.2020.118097_bb0310","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cyto.2017.12.010","article-title":"A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis","volume":"110","author":"Behfar","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2020.118097_bb0315","series-title":"Seminars in Immunopathology","article-title":"Cytokine storm and sepsis disease pathogenesis","author":"Chousterman","year":"2017"},{"issue":"2","key":"10.1016\/j.lfs.2020.118097_bb0320","first-page":"365","article-title":"Cytokine storm in avian influenza","volume":"42","author":"Us","year":"2008","journal-title":"Mikrobiyoloji bulteni"},{"key":"10.1016\/j.lfs.2020.118097_bb0325","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Molecular Therapy-Oncolytics"},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0330","article-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","volume":"39","author":"Zhou","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2020.118097_bb0335","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.lfs.2020.118097_bb0340","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0147-9","article-title":"Alveolar type 2 progenitor cells for lung injury repair","volume":"5","author":"Olajuyin","year":"2019","journal-title":"Cell death discovery"},{"key":"10.1016\/j.lfs.2020.118097_bb0350","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0355","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/22221751.2020.1732837","article-title":"Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity","volume":"9","author":"Chen","year":"2020","journal-title":"Emerging microbes & infections"},{"key":"10.1016\/j.lfs.2020.118097_bb0360","first-page":"100029","article-title":"SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the \u2018culprit lesion\u2019 of ARDS onset? What is there besides Tocilizumab? SGP130Fc","author":"Magro","year":"2020","journal-title":"Cytokine: X"},{"key":"10.1016\/j.lfs.2020.118097_bb0365","series-title":"Macrophages: A Trojan Horse in COVID-19?","author":"Park","year":"2020"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0370","first-page":"1","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal transduction and targeted therapy"},{"issue":"8","key":"10.1016\/j.lfs.2020.118097_bb0375","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.4049\/jimmunol.169.8.4288","article-title":"IL-19 induces production of IL-6 and TNF-\u03b1 and results in cell apoptosis through TNF-\u03b1","volume":"169","author":"Liao","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118097_bb0380","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0385","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12916-017-0930-5","article-title":"Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis","volume":"15","author":"Kyriazopoulou","year":"2017","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.lfs.2020.118097_bb0390","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","article-title":"Two-way interactions between inflammation and coagulation","volume":"15","author":"Levi","year":"2005","journal-title":"Trends in cardiovascular medicine"},{"issue":"4","key":"10.1016\/j.lfs.2020.118097_bb0395","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.179.4.1253","article-title":"Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees","volume":"179","author":"Van der Poll","year":"1994","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2362.1997.570614.x","article-title":"The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia","volume":"27","author":"Levi","year":"1997","journal-title":"Eur. J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.lfs.2020.118097_bb0405","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0410","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40744-018-0102-x","article-title":"A review of recent advances using tocilizumab in the treatment of rheumatic diseases","volume":"5","author":"Rubbert-Roth","year":"2018","journal-title":"Rheumatology and therapy"},{"key":"10.1016\/j.lfs.2020.118097_bb0415","first-page":"10970","article-title":"Effective treatment of severe COVID-19 patients with Tocilizumab","volume":"117.20","author":"Xu","year":"2020","journal-title":"ChinaXiv preprint"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"18","author":"Fu","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2020.118097_bb0425","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","author":"Toniati","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2020.118097_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2020.05.001","article-title":"Tocilizumab therapy reduced intensive care unit admissions and\/or mortality in COVID-19 patients","author":"Klopfenstein","year":"2020","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.lfs.2020.118097_bb0435","article-title":"Feasibility of Tocilizumab in ICU patients with COVID-19","author":"Issa","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2020.118097_bb0440","first-page":"1","article-title":"Tocilizumab for the treatment of severe COVID-19","author":"Alattar","year":"2020","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0445","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diii.2020.03.010","article-title":"Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab","volume":"101","author":"Cellina","year":"2020","journal-title":"Diagnostic and Interventional Imaging"},{"key":"10.1016\/j.lfs.2020.118097_bb0450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejim.2020.05.009","article-title":"Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia","volume":"76","author":"Capra","year":"2020","journal-title":"European journal of internal medicine"},{"key":"10.1016\/j.lfs.2020.118097_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25855","article-title":"Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome","author":"Odi\u00e8vre","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lfs.2020.118097_bb0460","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","author":"Somers","year":"2020","journal-title":"medRxiv"},{"issue":"7","key":"10.1016\/j.lfs.2020.118097_bb0465","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood advances"},{"key":"10.1016\/j.lfs.2020.118097_bb0470","doi-asserted-by":"crossref","DOI":"10.7326\/L20-0419","article-title":"Tocilizumab for hemophagocytic syndrome in a kidney transplant recipient with COVID-19","author":"Faguer","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lfs.2020.118097_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.05.005","article-title":"Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients","author":"Marfella","year":"2020","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.lfs.2020.118097_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25907","article-title":"Letter to the editor: acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab","author":"Morrison","year":"2020","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0485","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.chest.2020.04.024","article-title":"Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: a cautionary case report","volume":"158","author":"Radbel","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118097_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106009","article-title":"Tocilizumab in COVID-19: beware of risk of intestinal perforation","author":"Vikse","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.lfs.2020.118097_bb0495","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.lfs.2020.118097_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006640","article-title":"Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology","volume":"13","author":"Pyle","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2020.118097_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/ejhpharm-2020-002322","article-title":"Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19","author":"Palanques-Pastor","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.lfs.2020.118097_bb0510","article-title":"Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support","author":"Gritti","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.lfs.2020.118097_bb0515","article-title":"A systematic review of Anakinra, Tocilizumab, Sarilumab and Siltuximab for coronavirus-related infections","author":"Khan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.lfs.2020.118097_bb0520","article-title":"A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19","author":"Ge","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0525","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13046-018-0938-5","article-title":"Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.lfs.2020.118097_bb0530","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"75","author":"Zhou","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0535","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Bioscience trends"},{"key":"10.1016\/j.lfs.2020.118097_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.lfs.2020.118097_bb0545","article-title":"Hydroxychloroquine and Tocilizumab therapy in COVID-19 patients-an observational study","author":"Ip","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.lfs.2020.118097_bb0550","series-title":"Lack of Benefit in COVID-19 Patients Treated With Hydroxychloroquine or Chloroquine: A Systematic Review and Meta-Analysis","author":"Chen","year":"2020"},{"key":"10.1016\/j.lfs.2020.118097_bb0555","series-title":"Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What every Clinician Should Know","author":"Yazdany","year":"2020"},{"key":"10.1016\/j.lfs.2020.118097_bb0560","unstructured":"Singh, R. and V. Vijayan, Chloroquine: a potential drug in the COVID-19 scenario. Transactions of the Indian National Academy of Engineering: p. 1\u201312."},{"key":"10.1016\/j.lfs.2020.118097_bb0565","series-title":"Thalidomide Combined With Low-Dose Glucocorticoid in the Treatment of COVID-19 Pneumonia","author":"Chen","year":"2020"},{"issue":"6","key":"10.1016\/j.lfs.2020.118097_bb0570","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"4\u20135","key":"10.1016\/j.lfs.2020.118097_bb0575","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0959-8049(92)90134-N","article-title":"Lymphocyte infiltrates as a prognostic variable in female breast cancer","volume":"28","author":"Aaltomaa","year":"1992","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0580","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-019-1964-1","article-title":"Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations","volume":"21","author":"McInnes","year":"2019","journal-title":"Arthritis research & therapy"},{"issue":"4","key":"10.1016\/j.lfs.2020.118097_bb0585","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0590","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118097_bb0595","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00395-012-0263-7","article-title":"The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2\/STAT3 signaling pathway","volume":"107","author":"Duan","year":"2012","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0600","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jnutbio.2012.03.012","article-title":"Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart","volume":"24","author":"Pan","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"10","key":"10.1016\/j.lfs.2020.118097_bb0605","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.biocel.2004.01.030","article-title":"Curcumin modulates free radical quenching in myocardial ischaemia in rats","volume":"36","author":"Manikandan","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1\/A","key":"10.1016\/j.lfs.2020.118097_bb0610","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2020.118097_bb0615","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.phrs.2016.07.004","article-title":"Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Derosa","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2020.118097_bb0620","first-page":"168","article-title":"Anti-inflammatory responses of resveratrol","volume":"6","author":"Das","year":"2007","journal-title":"Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)"},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0625","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0022-3565(24)39074-3","article-title":"Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth","volume":"294","author":"Moreno","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0630","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1159\/000343318","article-title":"Sirt1 regulates cd40 expression induced by tnf-\u03b1 via nf-\u0138b pathway in endothelial cells","volume":"30","author":"Yang","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2253-8","article-title":"Effective inhibition of MERS-CoV infection by resveratrol","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118097_bb0640","first-page":"e13535","article-title":"Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2\/COVID-19","author":"Marinella","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.lfs.2020.118097_bb0645","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2015.12.011","article-title":"Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma","volume":"244","author":"Aroui","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.lfs.2020.118097_bb0650","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00011-010-0295-0","article-title":"Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation","volume":"60","author":"Jain","year":"2011","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0655","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12906-019-2535-3","article-title":"Anti-inflammatory effect of naringin and sericin combination on human peripheral blood mononuclear cells (hPBMCs) from patient with psoriasis","volume":"19","author":"Deenonpoe","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2020.118097_bb0660","series-title":"Citrus Fruits Are Rich in Flavonoids for Immunoregulation and Potential Targeting ACE2","author":"Cheng","year":"2020"},{"key":"10.1016\/j.lfs.2020.118097_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2015.11.019","article-title":"Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat","volume":"243","author":"Chtourou","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2020.118097_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0675","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12906-017-1585-7","article-title":"The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function","volume":"17","author":"Ding","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"10","key":"10.1016\/j.lfs.2020.118097_bb0680","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.7150\/ijbs.45538","article-title":"Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"24","key":"10.1016\/j.lfs.2020.118097_bb0685","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/S0024-3205(02)01541-2","article-title":"Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function","volume":"70","author":"Chen","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118097_bb0690","first-page":"1","article-title":"Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs","author":"Luo","year":"2020","journal-title":"Chinese journal of integrative medicine"},{"issue":"10","key":"10.1016\/j.lfs.2020.118097_bb0695","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/CCM.0000000000002570","article-title":"Efficacy and safety of combination therapy of Shenfu injection and postresuscitation bundle in patients with return of spontaneous circulation after in-hospital cardiac arrest: a randomized, assessor-blinded, controlled trial","volume":"45","author":"Zhang","year":"2017","journal-title":"Crit. Care Med."},{"issue":"11","key":"10.1016\/j.lfs.2020.118097_bb0700","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s001340050735","article-title":"Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy","volume":"24","author":"Christman","year":"1998","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.lfs.2020.118097_bb0705","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11655-008-0051-2","article-title":"Role of Shenfu injection (\u53c2\u9644\u6ce8\u5c04\u6db2) in rats with systemic inflammatory response syndrome","volume":"14","author":"Wang","year":"2008","journal-title":"Chinese journal of integrative medicine"},{"key":"10.1016\/j.lfs.2020.118097_bb0710","first-page":"027","article-title":"Influence of Shenfu injection on inflammatory cytokines and prognosis in patients with severe sepsis","volume":"3","author":"Zhang","year":"2011","journal-title":"Chin. Arch. Tradit. Chin. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:14:16Z","timestamp":1765228456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520308481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":142,"alternative-id":["S0024320520308481"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118097","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118097"}}